In The News
Featured Evidence
- November 11, 2022
WISDM Trial: Hypoglycemia Avoidance Associated with rtCGM Sustained Out to 12 Months in Older Adults
Learn MoreThe Wireless Innovation for Seniors with Diabetes Mellitus (WISDM) randomized clinical trial (RCT) featured a 26-week phase comparing real-time continuous glucose monitoring (RT-CGM) with blood glucose monitoring (BGM) in 203 adults aged ≥60 years with type 1 diabetes (T1D). Of the 198 participants who completed the RCT, 98% of RT-CGM group participants continued (CGM-CGM cohort)...
- June 21, 2021
Effect of Continuous Glucose Monitoring on Glycemic Control in Patients with Type 2 Diabetes Treated with Basal Insulin: A Randomized Clinical Trial
Learn More
- June 23, 2021
Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated Diabetes
Learn More
Latest Expert Interview
Addressing Disparities in Care with Evidence-Based Utilization of Diabetes Technology
Expert: Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP, Endocrine Clinical Pharmacy Specialist, Co-Director, Endocrine Disorders in Pregnancy, Cleveland Clinic Endocrinology & Metabolism Institute
Summary: Opportunities to improve care quality and reduce costly resource utilization in diverse patient populations with evidence-based utilization of CGM
Watch Now View All Interviews-
October 3, 2022Continuous Glucose Monitoring: An Opportunity for Population-Based Diabetes Management
Source: Population Health Management Programmatic integrated approaches have been used successfully and cost-effectively to manage various chronic conditions. The incorporation of rtCGM in similar integrated approaches to diabetes management presents an opportunity to improve quality outcomes and reduce costs on a population level. This publication details the evidence to suggest it may be time to…
-
September 15, 2022Stepping Forward With Real-Time Continuous Glucose Monitoring in the Primary Care Practice
CME INFORMATION Release Date: 9/15/2022 Expiration Date: 9/15/2023 TARGET AUDIENCEThis activity is intended for primary care physicians and internal medicine physicians. LEARNING OBJECTIVESUpon completion of this activity, participants will: Have increased knowledge regarding the Data supporting use of rtCGM in practice Have greater competence related to Implementing practical strategies forusing rtCGM in practice
-
July 15, 2022Latest Research in Diabetes Technology: Highlights from ATTD 2022
Recap of real-time continuous glucose monitoring (rtCGM) abstracts from the 15th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2022) – where innovation in diabetes medicines and treatments, cutting-edge technologies, and the latest research is presented. These abstracts are pertinent to managed care and payer decision makers and help characterize the value of…
-
May 19, 2022ADA Standards of Medical Care: Recommendations for Continuous Glucose Monitoring
The American Diabetes Association (ADA) Standards of Medical Care represent the latest evidence-based recommendations for guiding clinical practice. According to the most recent edition of these guidelines, Level A evidence from the MOBILE study supports the use of real time continuous glucose monitoring (rtCGM) in patients with insulin-treated type 2 diabetes (T2D) regardless of regimen….
-
March 9, 2022Expanding Medicaid Access to Continuous Glucose Monitors
Source: Center for Health Care Strategies Published: January 2022
-
-
-
Value of CGM
more patients using rtCGM achieve HEDIS-compliant HbA1C<8% compared with BGM
1
1. Karter AJ, et al. JAMA. 2021;325:2273-2284. doi: 10.1001/jama.2021.6530.
Click here to access
of patients report modifying lifestyle choices due to rtCGM feedback
2
2. Ehrhardt N, et al. Clin Diabetes. 2020;38:126-131. doi: 10.2337/cd19-0037.
Click here to access
in PMPM savings in T2 diabetes related costs according to claims analyses of rtCGM users
3, 4
3. Norman GJ, et al. Diabetes Technol Ther.
2022;24:520-524. doi: 10.1089/dia.2021.0525.
Click here to access
4. Isaacson B, et al. J Diabetes Sci Technol.
2022;16:383-389. doi: 10.1177/1932296820955228.
Click here to access
